Anti-CO4A3/ COL4A3 functional antibody
Anti-CO4A3/ COL4A3 functional antibody for cell culture, ELISA & in-vivo assay
Go to COL4A3/COL4A3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE0800-Ab-1/ GM-Tg-hg-SE0800-Ab-2 | Anti-Human COL4A3 monoclonal antibody | Human |
GM-Tg-rg-SE0800-Ab-1/ GM-Tg-rg-SE0800-Ab-2 | Anti-Rat COL4A3 monoclonal antibody | Rat |
GM-Tg-mg-SE0800-Ab-1/ GM-Tg-mg-SE0800-Ab-2 | Anti-Mouse COL4A3 monoclonal antibody | Mouse |
GM-Tg-cynog-SE0800-Ab-1/ GM-Tg-cynog-SE0800-Ab-2 | Anti-Cynomolgus/ Rhesus macaque COL4A3 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE0800-Ab-1/ GM-Tg-felg-SE0800-Ab-2 | Anti-Feline COL4A3 monoclonal antibody | Feline |
GM-Tg-cang-SE0800-Ab-1/ GM-Tg-cang-SE0800-Ab-2 | Anti-Canine COL4A3 monoclonal antibody | Canine |
GM-Tg-bovg-SE0800-Ab-1/ GM-Tg-bovg-SE0800-Ab-2 | Anti-Bovine COL4A3 monoclonal antibody | Bovine |
GM-Tg-equg-SE0800-Ab-1/ GM-Tg-equg-SE0800-Ab-2 | Anti-Equine COL4A3 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE0800-Ab-1/ GM-Tg-hg-SE0800-Ab-2; GM-Tg-rg-SE0800-Ab-1/ GM-Tg-rg-SE0800-Ab-2; GM-Tg-mg-SE0800-Ab-1/ GM-Tg-mg-SE0800-Ab-2; GM-Tg-cynog-SE0800-Ab-1/ GM-Tg-cynog-SE0800-Ab-2; GM-Tg-felg-SE0800-Ab-1/ GM-Tg-felg-SE0800-Ab-2; GM-Tg-cang-SE0800-Ab-1/ GM-Tg-cang-SE0800-Ab-2; GM-Tg-bovg-SE0800-Ab-1/ GM-Tg-bovg-SE0800-Ab-2; GM-Tg-equg-SE0800-Ab-1/ GM-Tg-equg-SE0800-Ab-2 |
Products Name | Anti-COL4A3 monoclonal antibody |
Format | mab |
Target Name | COL4A3 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-COL4A3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE0800-Ag-1 | Recombinant multi-species CO4A3/ COL4A3 protein |
Target information
Target ID | GM-SE0800 |
Target Name | COL4A3 |
Gene ID | 1285,12828,363265,712444,403842,101087512,317711,100037402 |
Gene Symbol and Synonyms | alpha3(IV),ATS2,ATS3,BFH2,COL4A3,TUM5,[a]3(IV) |
Uniprot Accession | Q01955,Q28084 |
Uniprot Entry Name | CO4A3_HUMAN,CO4A3_BOVIN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000169031 |
Target Classification | N/A |
The target: COL4A3, gene name: COL4A3, also named as . Type IV collagen, the major structural component of basement membranes, is a multimeric protein composed of 3 alpha subunits. These subunits are encoded by 6 different genes, alpha 1 through alpha 6, each of which can form a triple helix structure with 2 other subunits to form type IV collagen. This gene encodes alpha 3. In the Goodpasture syndrome, autoantibodies bind to the collagen molecules in the basement membranes of alveoli and glomeruli. The epitopes that elicit these autoantibodies are localized largely to the non-collagenous C-terminal domain of the protein. A specific kinase phosphorylates amino acids in this same C-terminal region and the expression of this kinase is upregulated during pathogenesis. This gene is also linked to an autosomal recessive form of Alport syndrome. The mutations contributing to this syndrome are also located within the exons that encode this C-terminal region. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jun 2010].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.